AK
Arthur Kuan
DELAYED 1 MONTH
Director, Chief Executive Officer
CG Oncology, Inc.
Filings
2
Companies
1
Latest
Mar 12, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
—
CG Oncology, Inc.
Arthur Kuan
Director, Chief Executive Officer
Option Exercise
$111.1K
64,612 sh
Mar 13 8:09 PM
Mar 12, 2026
—
CG Oncology, Inc.
Arthur Kuan
Director, Chief Executive Officer
Option Exercise
$176.9K
102,871 sh
Mar 6 10:52 PM
Mar 4, 2026